Genetic analysis services by Prof. Roberto Grobman right now: How we do it? We created a series of complex interconnected algorithms together with AI technology, capable of translating the scientific data and results of these scientific publications into useful information, and over the years we have been creating a unique FullDNA database. Our solution shows patients with a superior high accuracy rate what is written in their DNA, providing an excellent tool to understand what can happen and to act immediately to live longer and healthier. FullDNA provides an AI based customizable genetics prediction premium health tech platform to empower the capability of health professionals and institutions. FullDNA analyzes results from DNA sequencing Big Data using AI and complex algorithms to compares it with our own valuable extracted Database (updated daily) of more than 5,000 diseases and medical conditions, resulting in output of analysis & recommendation reports in various fields of medicine. Discover extra details at Roberto Grobman.

DNA can tell you everything from your ancestry to pharmacogenomics (‘smart medicine’). For example, we can use DNA testing to help you understand how you metabolise medication: are you a slow or fast metaboliser? Are there certain drugs that might cause an adverse reaction? Pharmacogenetic information could be critically important for someone with a recent diagnosis of a condition such as coronary vascular disease. If you suffer from it, you might have to endure the merry-go-round of trying different drugs to identify the right ones for you. This means delays in receiving the right kind of medication, which can impact costs as well as your recovery.

High quality DNA report services by Roberto Grobman: As results are provided directly to the individual, they are not in your insurance or medical record (unless you share results with your healthcare professional). It is often less expensive than genetic testing obtained through a healthcare provider, which can make testing more accessible to people with no or limited health insurance. DNA sample collection is usually simple and noninvasive, and results are available quickly. Your anonymous data is added to a large database that can be used to further medical research. Depending on the company, the database may represent up to several million participants.

Consider the example of familial hypercholesterolemia (FH), a condition in which multiple variants of several different genes lead to markedly high cholesterol. This greatly increases the risk of heart attack, stroke, and other health problems. FH affects about one in 300 adults, which means it isn’t rare. Among adults who have the most common genetic variants that cause it, heart attack or sudden cardiac death may occur in middle age. Children who have a double dose of a gene variant linked to this condition may die of cardiovascular disease before age 20. Earlier treatments intended to reduce the risk of complications, such as cholesterol-lowering drugs, are available if a child or adult is known to have a mutation linked to FH.

Since the sequencing of the first genome, innovations have fuelled reduced sequencing times, which have in turn reduced costs. Today we are able to use that cutting-edge technology to understand how to use your DNA to live with the best possible health — to get the most out of your DNA and yourself. The road to DNA health testing: With anything that relates to clinical care, we always need sufficient evidence before we can ‘know’ something and make recommendations. In some cases, the research can take 10 years before there are proven outcomes, before it’s appropriate to bring to the general population or implement a large-scale deployment.

Our mid-level genetic report encompasses broader sets of relevant genomic variants for Health and Wellness Panels. Essential Reports provide patient-specific information, determined by his genetics, which allows the user to know what their genetic tendencies are, with additional information than the First Panel, thus maintaining their Health, Vitality, Beauty and Longevity. FullDNA CEO Roberto Grobman says that the University of Washington provided some samples of the Covid-19 receptor for the development of the research. Read more info on Roberto Grobman CTO.